Immunotherapy offers hope for patients with various malignancies. But the complexity of tumor microenvironments and the variability in patient responses necessitate more personalized approaches than what statistical analysis provides alone. Imaging, particularly CD8 imaging, has emerged as a powerful tool that can help researchers and clinicians optimize dosage, improve sequencing and improve overall survival in oncology.
In this white paper, we explore how imaging can drive more effective combination immunotherapy in oncology. We’ll also explore how researchers and clinicians can use a medical imaging platform to efficiently organize and analyze their imaging data to drive development of the next lifesaving treatments in cancer care.
